SEA Funding Q2 2025 Rebound: Three Reasons I'm Cautiously Reading It

Originally published: 2025-06 | Last verified: 2026-05-06 Statistics in this article have been verified against Tracxn quarterly aggregations, A2D Ventures H1 2025 reporting, and Tech Collective SEA analysis current as of May 2026. Quarterly funding data is volatile on individual large rounds; please refer to primary sources for current figures.

The numbers from the first half of 2025 read like a clean SEA venture capital rebound story. Total tech startup funding for H1 2025 came in at approximately USD 2 billion, roughly 7% higher year-over-year. Late-stage funding specifically surged by ~140% over H2 2024, reaching ~USD 1.4 billion. Q2 2025 added USD 1.09 billion to the Q1 baseline of USD 909 million, a quiet but meaningful sequential acceleration. (Source: Tracxn H1 2025 SEA report; A2D Ventures rebound analysis; Tech Collective SEA reporting.)

The headline framing in the regional press has been “SEA is recovering.” It’s a tempting read. It is also, in my view, the wrong framing for what the data actually shows. The H1 2025 numbers fit much more cleanly into the funding reallocation framework I outlined in the SEA pillar piece — late-stage capital concentrating into a narrowing set of survivors with proven unit economics, against a backdrop of continued seed-stage caution — than into a “broad-based recovery” narrative.

Three reasons to be cautious about reading H1 2025 as a recovery, rather than as a deeper continuation of the reallocation story.

Reason 1: The recovery is concentrated in a small number of large rounds

The first thing the headline numbers obscure is the deal-count distribution. H1 2025’s USD 2 billion did not arrive distributed across a healthy population of rounds. It arrived concentrated in a small number of large late-stage transactions, with the underlying deal count remaining at multi-year lows.

Practitioner aggregations from the period showed Q1 2025 deal count for SEA tech sitting at roughly 100-110 deals — the lowest quarterly count since 2018-2019. Q2 2025 deal count was modestly higher but remained well below the 2021-2022 peak quarterly counts of 200-300 deals. The dollar volume came back; the deal count did not.

What this means is that the average deal size rose substantially. Median Series C+ ticket sizes in H1 2025 were, by my read, 2-3x the median of late 2023. The capital was available, but it was being deployed selectively into a smaller set of companies that had survived the 2022-2024 funding winter and demonstrated durable unit economics. The companies that did not have that demonstrated economics, particularly at seed and Series A, continued to face a structurally tighter market.

This is what reallocation looks like in deal-count form. Capital concentrating in winners, not capital broadening across the ecosystem.

We turned down 4-5 times more pitches in Q2 2025 than we did in Q2 2022, but we wrote our largest individual checks of the cycle to the survivors that were unequivocally working. The aggregate dollar number is up; the breadth of the ecosystem participating is not.— Singapore-based Series B partner, regional fund

Reason 2: The late-stage surge is structural, not cyclical

The ~140% H1 2025 increase in late-stage funding versus H2 2024 looks dramatic, but the right comparison is not H2 2024. The right comparison is the long-run pre-correction baseline.

Set against H1 2022 — the late-cycle peak before the SEA correction took hold — H1 2025’s late-stage figure is roughly half. The 140% rebound off the H2 2024 trough recovers a fraction of the prior peak, not most of it. The right framing is that late-stage is reverting from extreme depression toward a new, lower equilibrium — not that late-stage is recovering toward the prior peak.

This matters for thesis underwriting. A “we’re back to where we were” framing implies that the broader ecosystem dynamics that drove the 2021-2022 cycle are returning. They are not. What is happening is that the late-stage capital that was sitting on the sidelines through 2023-2024 is now deploying into the post-correction survivors, at a deployment rate that probably stabilizes near current H1 2025 levels for several quarters rather than continuing to climb.

The structural read: late-stage SEA funding is settling into a new range of USD 600M-1B per quarter, dominated by 5-10 large transactions per quarter. That is a healthier equilibrium than H2 2024, but it is qualitatively different from the 2021-2022 cycle.

Reason 3: The seed and Series A stages are not participating

The third reason for caution is the most important: the H1 2025 rebound is conspicuously absent at the seed and Series A stages. Tracxn and other practitioner aggregations consistently showed seed funding flat-to-down year-over-year, and Series A funding tracking similar dynamics, despite the late-stage surge.

This pattern has implications. The pipeline of companies that will reach late-stage maturity in 2027-2028 is being funded today at rates that are significantly lower than the 2021-2022 cohort. Even with the assumption that today’s seed companies have better unit economics on average than the 2021-2022 cohort, the absolute dollar volume of seed deployment limits how many late-stage opportunities the ecosystem can produce two to three years out.

What the 2025 late-stage surge will not do is create the next 2021-2022 vintage. The capital being deployed today is going into companies that were funded in 2019-2021 — the cohort that has weathered the cycle and demonstrated viability. The companies being seed-funded in 2024-2025 are a smaller cohort, with tighter selection criteria, that will produce a smaller late-stage opportunity set in 2027-2028 than the current cohort produced in 2024-2025.

The forward-looking implication for LPs is that the SEA late-stage opportunity through 2026-2028 may be relatively concentrated and competitive — fewer late-stage companies attracting more late-stage capital — but the period beyond that depends on what happens to seed and Series A funding patterns over the next 18 months.

What the cautious framework looks like

Pulling these three reasons together, the framework I’d use to read H1 2025 and forward is:

The “reallocation” reading is the framework I’d advocate. It accepts the data, doesn’t deny the late-stage activity, and reads the underlying texture honestly.

What this means for capital allocation

For LPs allocating to SEA-focused funds in 2026-2027, the practitioner takeaways are three:

Re-evaluate vintage exposure. The 2024-2025 vintage of SEA funds is being constructed in a meaningfully different market than the 2021-2022 vintage. Smaller deal counts, larger ticket sizes, more concentration into late-stage opportunities. The portfolio construction implications are substantial: more concentrated portfolios, longer holding periods, potentially better IRR profiles per company but lower portfolio diversification. LPs evaluating these vintages should expect different return distribution shapes than the 2021-2022 vintage produced.

Beware the “we’re back” thesis. Fund managers raising new SEA vintages in 2026 will be tempted to frame H1 2025 as “the rebound” and pitch portfolio construction implicitly assuming a return to broad-based ecosystem activity. The data does not support that framing. Underwriting should assume a continued narrow-and-deep capital deployment environment for the foreseeable future.

Watch the seed-and-Series-A pipeline. The leading indicator for SEA’s late-stage opportunity in 2027-2028 is the seed-and-Series-A activity in 2024-2025. If those stages remain weak through 2026, the late-stage opportunity set narrows further into 2027-2028. If they recover, the late-stage opportunity set broadens again. This is the variable I’d track most carefully over the next 12-18 months.

What might shift the cautious read

Two things that could change the framework, ordered by my probability estimate.

Continued AI-driven deployment expansion. A meaningful portion of the H1 2025 late-stage volume went into AI-adjacent companies — vertical AI applications, AI infrastructure plays serving SEA enterprises, generative-AI-enabled productivity tools. If AI deployment continues to expand the addressable opportunity set for SEA-focused investing, some of the seed/Series A weakness could reverse as new AI-native companies enter the pipeline. This is the most likely source of upside to my cautious read.

A China-adjacent capital reallocation. If a meaningful portion of the capital that has historically gone to China-focused VC redirects toward SEA — driven by mainland-China political risk perception or by China’s continuing economic deceleration — the SEA ecosystem could see a step-up in available capital that broadens beyond the current narrow concentration. This would be a multi-year shift but the directional pressure exists.

Neither of these is the base case. The base case remains: SEA H1 2025 is the reallocation story playing out at a slightly higher absolute capital level than 2024, with continued narrowness in deal count and continued weakness at the early stages. Read it as such, and the SEA opportunity set looks different — and probably better-priced — than the recovery framing implies.